3.5K Expected at AMCP meeting in San Antonio | AMCP 2023
A pavilion devoted to prescription digital therapeutics and an educational track devoted to biosimilars are new this year.
Officials at the Academy of Managed Care Pharmacy (AMCP) are expecting the 3,500 attendees at the organization’s meeting San Antonio, Texas, a 19% increase over the attendance at meeting in Chicago.
The meeting, which stared with slate of pre-conference sessions today, kicks off tomorrow and ends on Friday. It is being held at the Henry B. González Convention Center.
Robin Roberts is scheduled to speak at a general session Wednesday afternoon at the annual meeting of the Academy of Managed Care Pharmacy (AMCP).
Robin Roberts, the co-anchor of ABC’s Good Morning America, is scheduled to address a general session of the meeting tomorrow at 1:30 p.m. Douglas Long, MBA, vice president, industry relations, IQVIA and a regular speaker at AMCP meetings, is scheduled to give the keynote Thursday morning at 8 a.m.
The meeting organizers said the exhibit hall at the meeting will have about 70 exhibitors.
AMCP has been a backer of prescription digital therapeutics (PDTs)and new to the meeting this year is a pavilion devoted to PDT companies and their wares. Another innovation is track devoted to biosimilars.
The meeting also has sessions on topics that are featured at most AMCP meeting, such as the drugs in late-stage development (“the pipeline”), updates on legislation, and healthcare disparities. The meeting also has numerous sessions on particular diseases and managed care issues.
Emerging Therapies Committee at UC Davis Hits the Accelerator Not the Brake | AMCP 2024
April 18th 2024After the onboarding of cell and gene therapy bogged using normal pharmacy and therapeutics (P&T) committee procedures, UC Davis Health set up an emerging therapeutics committee to streamline and speed up the process of delivery expensive cell and gene therapies.
Read More
David Calabrese of OptumRx Talks New Role, Market Insulin Prices and Other Topics 'On His Mind'
April 13th 2023In this month’s episode of the "What's On Your Mind podcast," Peter Wehrwein, managing editor of MHE connects with the now Chief Clinical Officer of OptumRx Integrated Pharmacies, David Calabrese. In this conversation, David touches on his transition in January as OptumRx’s former chief pharmacy officer and market president of health plans and PBMs to his new role as Chief Clinical Officer where he now focuses more on things such as specialty pharmacy to home delivery — with an overall goal of creating whole-patient care. Throughout the conversation, Calabrese also touched on the market’s hot topic of insulin prices and behavioral health services within the OptumRx community, among other topics.
Listen
Potential Generics Could Lower Prices for Oncology, Cardiovascular Drugs | AMCP 2024
April 18th 2024Up to 50 generics could be approved this year, including Victoza to treat patients with diabetes. If generics of Victoza become available, this would the first GLP-1 to face generic competition.
Read More
Briana Contreras, editor of Managed Healthcare Executive, spoke with Nancy Lurker, CEO and president of EyePoint Pharmaceuticals. Nancy shared a bit about EyePoint and how the organization’s innovative therapies are addressing patient needs through eye care, and most importantly, she addressed C-Suite positions like the CEO role. Nancy shared advice for those seeking to reach the CEO level, especially toward women in healthcare and other roles, and what it takes to run a biopharma company.
Listen
Are Value-Based Contracts the Answer to Ultra-High-Priced Gene Therapies? | AMCP 2024
April 17th 2024Innovative contracts are becoming more common for gene therapies. They aim to balance a therapy’s cost-effectiveness and affordability, as well as address the uncertainty of long-term benefit.
Read More
